NKF Spring Clinical Meetings

NKF Spring Clinical Meetings

NKF is proud to present Spring Clinical Meetings in Boston, MA on April 6-10, 2022.

Boston skyline painted with watercolors

SCM22 Overview

SCM presents a unique opportunity for busy renal health care providers to learn new developments related to all aspects of nephrology. It is designed for nephrologists in the private sector and academia, fellows and residents with a special interest in kidney disease, general internists, pharmacists, physician assistants, nurse practitioners, nurses and technicians, social workers, renal and clinical dietitians, and transplant coordinators. 

SCM22 Quick Facts

  • Educational sessions across 8 program tracks
  • Live and virtual attendance options
  • CME, CE, and MOC available
  • Professional networking opportunity
  • Learn the newest developments in kidney care
  • Engage with exhibitors and poster presenters


Attendees have the option to select an in-person or virtual attendance option. Our virtual option, SCM-On-Demand includes recorded session access available 48 hours after their live presentation through June 15, 2022.

In accordance with Boston’s B Together Vaccine Mandate, all In-Person event attendees must be fully vaccinated by March 18, 2022 to attend SCM22.

Become an NKF member to receive discounted registration to SCM.

Rooms are available at Boston Marriott Copley Place, Sheraton Boston Hotel, and Westin Copley Place Boston. Advance Housing Deadline: March 4, 2022.

SCM22 Keynote Speaker: Dr. David R. Williams

Introducing our SCM22 Keynote Speaker

Introducing our SCM22 Keynote Speaker: Dr. David R. Williams, the Florence Sprague Norman and Laura Smart Norman Professor of Public Health and chair of the Department of Social and Behavioral Sciences at the Harvard T.H. Chan School of Public Health.

Tune into the NKF Presidential Address and Keynote Presentation on April 7, 2022 at 2:15pm ET.

Outstanding poster winner from SCM19

Abstract Submission

Late-Breaking Submission is Now Open! Submit HERE 


Late-Breaking submissions must be the results of a major clinical trial or epidemiological study. In order for your abstract to be considered for review, it must meet this criteria.


Deadline: February 1, 2022 at 11:59pm EST. This deadline will not be extended.